768 related articles for article (PubMed ID: 22161409)
21. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.
O'Shea O; Stovold E; Cates CJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD007694. PubMed ID: 33852162
[TBL] [Abstract][Full Text] [Related]
22. Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews.
Cates CJ; Wieland LS; Oleszczuk M; Kew KM
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD010314. PubMed ID: 24504983
[TBL] [Abstract][Full Text] [Related]
23. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthma.
Kew KM; Evans DJ; Allison DE; Boyter AC
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011438. PubMed ID: 26031392
[TBL] [Abstract][Full Text] [Related]
24. Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children.
Kew KM; Karner C; Mindus SM; Ferrara G
Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD009019. PubMed ID: 24343671
[TBL] [Abstract][Full Text] [Related]
25. Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease.
Fukuda N; Horita N; Kaneko A; Goto A; Kaneko T; Ota E; Kew KM
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD012066. PubMed ID: 37276335
[TBL] [Abstract][Full Text] [Related]
26. Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children.
Lasserson TJ; Ferrara G; Casali L
Cochrane Database Syst Rev; 2011 Dec; (12):CD004106. PubMed ID: 22161385
[TBL] [Abstract][Full Text] [Related]
27. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children.
Cates CJ; Karner C
Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD007313. PubMed ID: 23633340
[TBL] [Abstract][Full Text] [Related]
28. Combination inhaled corticosteroids and long-acting beta2-agonists for children and adults with bronchiectasis.
Goyal V; Chang AB
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD010327. PubMed ID: 24913725
[TBL] [Abstract][Full Text] [Related]
29. Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease.
Karner C; Cates CJ
Cochrane Database Syst Rev; 2012 Apr; 4(4):CD008989. PubMed ID: 22513969
[TBL] [Abstract][Full Text] [Related]
30. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
Kew KM; Mavergames C; Walters JA
Cochrane Database Syst Rev; 2013 Oct; (10):CD010177. PubMed ID: 24127118
[TBL] [Abstract][Full Text] [Related]
31. Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma.
Kew KM; Dahri K
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011721. PubMed ID: 26798035
[TBL] [Abstract][Full Text] [Related]
32. Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease.
Maqsood U; Ho TN; Palmer K; Eccles FJ; Munavvar M; Wang R; Crossingham I; Evans DJ
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012930. PubMed ID: 30839102
[TBL] [Abstract][Full Text] [Related]
33. Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease.
Nannini LJ; Cates CJ; Lasserson TJ; Poole P
Cochrane Database Syst Rev; 2007 Oct; (4):CD006829. PubMed ID: 17943918
[TBL] [Abstract][Full Text] [Related]
34. Combined corticosteroid and long acting beta-agonist in one inhaler for chronic obstructive pulmonary disease.
Nannini L; Cates CJ; Lasserson TJ; Poole P
Cochrane Database Syst Rev; 2004; (3):CD003794. PubMed ID: 15266502
[TBL] [Abstract][Full Text] [Related]
35. Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children.
Ni Chroinin M; Lasserson TJ; Greenstone I; Ducharme FM
Cochrane Database Syst Rev; 2009 Jul; (3):CD007949. PubMed ID: 19588447
[TBL] [Abstract][Full Text] [Related]
36. Combined corticosteroid and long-acting beta-agonist in one inhaler versus inhaled steroids for chronic obstructive pulmonary disease.
Nannini LJ; Cates CJ; Lasserson TJ; Poole P
Cochrane Database Syst Rev; 2007 Oct; (4):CD006826. PubMed ID: 17943917
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β
Ferguson GT; Darken P; Ballal S; Siddiqui MK; Singh B; Attri S; Holmgren U; de Nigris E
Adv Ther; 2020 Jun; 37(6):2956-2975. PubMed ID: 32335859
[TBL] [Abstract][Full Text] [Related]
38. Inhaled corticosteroids for stable chronic obstructive pulmonary disease.
Yang IA; Clarke MS; Sim EH; Fong KM
Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD002991. PubMed ID: 22786484
[TBL] [Abstract][Full Text] [Related]
39. Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis.
Oba Y; Keeney E; Ghatehorde N; Dias S
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012620. PubMed ID: 30521694
[TBL] [Abstract][Full Text] [Related]
40. Combination inhaled steroid and long-acting beta(2)-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease.
Karner C; Cates CJ
Cochrane Database Syst Rev; 2011 Mar; (3):CD008532. PubMed ID: 21412920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]